Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010–2020—Cohort Study Based on Administrative Data

Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010–2020—Cohort Study Based on Administrative Data

(1) Background: Targeted (TT) and immune checkpoint inhibitor (ICI) therapies have become available in the routine care of metastatic melanoma in recent years. (2) Objective: We compared mortality in patients with metastatic melanoma and different systemic therapies. (3) Methods: A retrospective coh...

Full description

Bibliographic Details
Main Authors: Thomas Datzmann, Jochen Schmitt, Saskia Fuhrmann, Martin Roessler, Friedegund Meier, Olaf Schoffer
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
metastatic melanoma
targeted therapy
immune checkpoint inhibitor therapy
survival
statutory health insurance data
Online Access:https://www.mdpi.com/2072-6694/13/24/6150

Internet

https://www.mdpi.com/2072-6694/13/24/6150

Similar Items